News und Analysen
Quotient Appoints Kimberly Anstett to its Board of Directors
Quotient Technology Inc. (NYSE: QUOT) (“Quotient” or the “Company”), the leading digital media and promotions technology company, today announced that it has appointed Kimberly Anstett to the
NanoString Launches Integrated Informatics to Facilitate Spatial Biology Research Using Next Generation Sequencing
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a seamless, cloud-based workflow that improves the
DGAP-News: M1 Kliniken AG announces financials for Q1-2022: further growth of Beauty segment; ongoing optimisation of Trade segment
DGAP-News: Eckert & Ziegler with Sales Growth in the First Quarter of 2022
Geratherm Medical AG: Voluntary delisting offer by JotWe GmbH published
DGAP-News: Eckert & Ziegler Cooperates with Czech Research Center UJF to Produce Pharmaceutical Alpha Radioisotopes
U.S. FDA Renews Annual DILIsym Software Licenses for 2022
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that the U.S. Food and Drug
STAAR Surgical Reports Record First Quarter Net Sales of $63.2 Million Up 25% Y/Y
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the
DGAP-News: M1 Kliniken AG: Supervisory Board adopts (consolidated) financial statements 2021 of M1 Kliniken AG. No deviations from the preliminary figures for financial year 2021 published at the end of March
DGAP-News: MediClin AG: Group sales for the 1st quarter of 2022 significantly above the previous year's figure
DGAP-News: Vita 34 AG: Special items reflected in significant decline in earnings despite operational success in fiscal 2021
DGAP-Adhoc: Vita 34 publishes revenue and earnings forecast for the 2022 financial year
DGAP-News: MicroVision to Participate in Upcoming Investor Conferences
Simulations Plus Successfully Delivers FDA-Funded Project
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical and biotechnology industries, today announced the completion of a newly funded
MD Medical Group Investments Plc: Results of the Annual General Meeting of Shareholders
MD Medical Group Investments Plc: MDMG reports 8% growth in Revenue in Q1 2022
DGAP-News: MicroVision Announces First Quarter 2022 Results
DGAP-News: MicroVision Releases Videos of Track Testing for Ground-Truth Data
DGAP-Adhoc: 2021 financial figures of Vita 34 AG expected to be significantly below market expectations due to several special effects on earnings development
Annual General Meeting - Shareholders approve all proposals of the Board of Directors
Simulations Plus Enters New Collaboration to Advance DDDPlus™ Software
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced a new
DGAP-News: MicroVision Inc.: MicroVision to Announce First Quarter 2022 Results on April 27, 2022
STAAR Surgical to Report First Quarter Results on May 4, 2022
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release
Simulations Plus to Present at the Berenberg Discover AI Seminar
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Vorläufige Zahlen für das 1. Quartal 2022 - Zunehmende Schwierigkeiten bei der Lieferung elektronischer Bauteile machen das untere Ende der Jahresprognose wahrscheinlich
